NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2024
Back to search
Official data from USPTO
NEXRUTINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/02/2024
Trademark type
Word
Nice classes
5
Filing date
12/02/2020
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/27/2023
First use in commerce
07/27/2023
Drawing code
4
Owner type
03
Owner location
Norcross, GA
Examiner
KOLODNER, LOUIS FRANCIS
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hi-Tech Pharmaceuticals, Inc.
Representatives
Gregory L. Hillyer HILLYER LEGAL, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/29/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/29/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/02/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/02/2024
IUAF
USE AMENDMENT FILED
04/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/27/2023
EX2G
SOU EXTENSION 2 GRANTED
10/25/2023
EXT2
SOU EXTENSION 2 FILED
10/25/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/25/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/05/2023
EX1G
SOU EXTENSION 1 GRANTED
04/03/2023
EXT1
SOU EXTENSION 1 FILED
04/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2022
PUBO
PUBLISHED FOR OPPOSITION
09/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/17/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/29/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/10/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/17/2021
GNSL
LETTER OF SUSPENSION E-MAILED
09/17/2021
CNSL
SUSPENSION LETTER WRITTEN
09/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/15/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/23/2021
GNRT
NON-FINAL ACTION E-MAILED
03/23/2021
CNRT
NON-FINAL ACTION WRITTEN
03/23/2021
DOCK
ASSIGNED TO EXAMINER
03/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2021
NWAP
NEW APPLICATION ENTERED
12/05/2020
Continuous trademark protection
Get notified about every new filing that threatens NEXRUTINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.